Enduring CME

International Society for the Study of Women's Sexual Health - ISSWSH Annual Meeting 2021
Enduring / On-Demand: Through March 7, 2022
Online

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society for the Study of Women's Sexual Health (ISSWSH). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME)
Amedco LLC designates this enduring material for a maximum of 20.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychologists (APA)
Amedco LLC designates this enduring material for a maximum of 20.00 psychologist contact hours.

The following state boards accept courses from APA providers for Counselors: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, MD, ME, MO, NC, ND, NH, NE, NJ, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WI, WY
MI: No CE requirements
The following state boards accept courses from APA providers for MFTs: AK, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IN, KS, MD, ME, MO, NE, NC, NH, NJ, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY
The following state boards accept courses from APA providers for Addictions Professionals: AK, AR, CO, CT, DC, DE, GA, IA, IN, KS, LA, MD, MO, MT, NC, ND, NE, NJ, NM, NY (outstate held)*, OK, OR, SC, UT, WA, WI, WY
MA / MFTs: Participants can self-submit courses not approved by the MAMFT board for review.
The following state boards accept courses from APA providers for Social Workers: AK, AR, AZ, CA, CO, DE, FL, GA, ID, IN, KY, ME, MN, MO, NE, NH, NM, OR, PA, VT, WI, WY
* If the activity is held live in the state of NY, then direct addictions board is required, ie: NAADAC. If the activity is held outside NY, is virtual, enduring or remote, it is considered "outstate" and this reciprocity applies.

Texas Physical Therapy Association (TX PT)
This activity has been approved by the Texas Board of Physical Therapy Examiners for 20.0 CCUs for PTs and PTAs.
Sponsor Name: International Society for the Study of Women’s Sexual Health
Course Approval Number: 48243.

States with reciprocity with Texas Physical Therapy Association: AL, AK, AZ, CT, DE, GA, HI, ID, IN, IA, KS, KY, LA, ME, MA, MI, MN, MI, MS, NE, NH, NC, ND, OR, RI, SC, SD, TN, UT, VT, VA, WA, WI, WY-updated 02/18

New York Board for Psychology (NY PSY)
Amedco is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0031. 20 hours enduring material.

Objectives - After Attending This Program You Should Be Able To
1. Examine key scientific discoveries in basic science in the field of sexual medicine, explore the underpinning organic factors of sexual function and dysfunction and their interplay with the psycho-social ones in women.
2. Apply principles of patient tailored management and assessment in the context of different cultural settings.
3. Share and explain the efficacy of pharmacological, hormonal, psychological, sex therapy, and physical therapy interventions as part of an integrated approach in female sexual medicine and women's health programs.

ISSWSH Grievance Policy
1. The person with a grievance will first try to informally resolve their grievance by contacting the ISSWSH Executive Office with the issue concerning the meeting, its delivery, the evaluation method, or technological issue.
2. If the aggrieved person is not satisfied with the resolution through informal means, the aggrieved person shall put their grievance in writing to Dr. Parish. Dr. Parish will then consult with appropriate personnel at the organizations that have approved the course to find fair methods of resolving the grievance.
3. If the aggrieved person is not satisfied with the solutions put forth, then they will be directed to put their grievance in writing and contact the appropriate organization, e.g. ISSWSH. Dr. Parish will abide by any decisions regarding resolution of the grievance.

If earlier action steps fail to resolve the problem AASECT should be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it.
https://drive.google.com/file/d/1VESE48wb--hZeMIjHZifMYomrDXhKexF/view

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.

First  Last Commercial Interest
 Graziottin  Alessandra  Alfasigma, Bayer, Gedeon-Richter, Lolipharm, Shionogi, Theramex: Speakers Bureau, Alfasigma, Angelini, Bayer, Fragron, Gedeon-Richter, Lolipharm, Shionogi: Consultant, Alfasigma, Mylan: Scientific/Medical Advisory Board Member
 Stanley E.  Althof  Nitro-C: Consultant
 Nicole  Cirino  Sage Therapeutics: Scientific/Medical Advisory Board Member
 AH  Clayton  Changes in Sexual Functioning Questionnaire, Guilford Publications, Ballantine Books/Random House: Patent Holder, Relmada Therapeutics, Inc, Janssen, Sage Therapeutics: Research Grant Site Principal Investigator, Mediflix LLC, Euthymics and S1 Biopharma: Stock Shareholder, Acadia, Alkermes, Allergan, AMAG Pharmaceuticals, Inc., Astellas, Fabre-Kramer, Ovoca Bio plc, PureTech Health, S1 Biopharma, Sage Therapeutics, Takeda/Lundbeck, WCG MedAvante-ProPhase: Consultant
 Darlene  Dreon  Madorra: Employee
 Brooke  Faught  IPSEN Innovation: Research Grant Site Principal Investigator, Trophikos : Consultant, Therapeutics MD:Speakers Bureau, JDS Therapeutics: Consultant, Lupin: Speakers Bureau
 W.  Fisher  Social Sciences and Humanities Research Council of Canada: Research Grant Overall Principal Investigator, Canadian Institutes of Health Research: Research Grant Site Principal Investigator
 Jean Michel  Foidart  MITHRA: Corporate Board Member
 David  Foster  Solutex Inc.: Research Grant Overall Principal Investigator, Maresins Pharma: Patent Holder
 Annamaria  Giraldi  Novo Nordic: Stock Shareholder, Eli Lilly: Consultant, Astellas: Speakers Bureau, Palatin Technologies: Scientific/Medical Advisory Board Member, OvacoBio: Scientific/Medical Advisory Board Member, Astellas: Speakers Bureau, Pfizer Inc: Speakers Bureau
 Irwin   Goldstein  AbbVie: Research Grant Site Principal Investigator, Lipocine: Consultant, Marius: Research Grant Site Principal Investigator, Sprout: Speakers Bureau, TRT: Speakers Bureau
 Joshua  Gonzalez  Astroglide Lubricants: Consultant, Sprout: Scientific/Medical Advisory Board Member
 Lyndsey  Harper  Rosy Wellness, Inc: Employee, Rosy Wellness, Inc: Stock Shareholder, Rosy Wellness, Inc: Corporate Board Member
 Martha  Hickey  Madorra: Research Grant Site Principal Investigator
 Heather  Howard  Ergoerotics: Founder
 Alyse  Kelly-Jones  Therapeutics MD: Speakers Bureau, Sprout Pharma: Speakers Bureau, Lupin: Consultant, Astellas: Consultan
 Noel  Kim  Sprout Pharmaceuticals: Consultant, Strategic Science and Technologies: Consultant
 Choll  Kim  Lumenis: Consultant, Globus Medical: Consultant, Elliquence: Speakers Bureau
 Sheryl  Kingsberg  Ovoca, Astellas, Mitsubishi Tanaba: Consultant, Endoceutics: Consultant, AMAG Pharmaceuticals, Inc.: Scientific/Medical Advisory Board Member, Palatin Technologies, Inc.: Consultant, Pfizer, Lupin, Materna: Consultant, Dare:Research Grant Site Principal Investigator, dare: Consultant, TherapeuticsMD: Speakers Bureau,TherapeuticsMD:Consultant,Sprout:Consultant,Emotional Brain:Scientific/Medical Advisory Board Member, Strategic Science Technologies: Consultant
 Barry  Komisaruk  Apex Neuro: Consultant
 Andrew  London  Mayne Pharamceutics: Scientific/Medical Advisory Board Member
 Becky  Lynn  TherapeuticsMD: Speaker, AMAG: Speakers Bureau, Viveve: Speakers Bureau
 Elizabeth  Mahar  Rosy Wellness, Inc: Consultant
 Sharon  Parish  AMAG: Writing support, no compensation, Strategic Science Technologies: Consultan
 Chelsea  Powers   Rosy Wellness: Employee
 Holly  Rockweiler  Madorra: Stock Shareholder, Madorra: Employee, Madorra: Corporate Board Member, Madorra: Patent Holder
 Tami   Rowen  TherapeuticsMD: Scientific/Medical Advisory Board Member
 RS  Rubin  IPSEN: Research Grant Site Principal Investigator, Sprout: Consultant
 Elizabeth  Sarkar  Lupin: Consultant
 L.   Vignozzi  Received funding from the following companies for scientific research, advisory Board attendance, speaker honoraria: Therascience; Theramex; Bayer-Schering Pharma, Intercept, Lipocine Ibsa:

ISSWSH/ISSM Joint Meeting 2025
February 27 - March 2, 2025
65 days left
Grand Hyatt Atlanta - Atlanta, GA
Visit the Meeting Website

ISSWSH Fall Course 2025   
November 13-16, 2025
326 days left  
 We-Ko-Pa Casino Resort  - Fort McDowell, AZ
Visit the Course Website

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.